로딩 중…
지수 로딩 중…
Novartis AG
NVS· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
CH
CH$147.09-2.51%
2026-06-18
Price Chart
Novartis AG+26.85%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $280.66B |
| Revenue | $56.05B |
| Net Income | $13.53B |
| Total Assets | $118.53B |
| Net Assets | $38.51B |
| Value | |
| P/E | 20.74x |
| P/B | 7.29x |
| P/S | 5.01x |
| EV/EBITDA | 14.32x |
| FCF Yield | 5.83% |
| Profitability | |
| ROE | 35.14% |
| ROA | 11.42% |
| Op. Margin | 30.54% |
| Revenue Growth | -0.70% |
| Earnings Growth | -12.48% |
| Financial Health | |
| Debt Ratio | 206.70% |
| Total Debt | $47.00B |
| FCF | $16.36B |
| Cash | $6.88B |
| Current Ratio | 0.85x |
| Net Debt/EBITDA | 1.79x |
| Dividend | |
| Div. Yield | 3.11% |
| Div. Growth | 3.07% |
| Performance | |
| 1Y Return | 26.85% |
| 1M Return | -2.23% |
| From 52W High | -13.71% |
| 1Y MDD | -15.23% |
| Trading | |
| Volume | 1,673,111 shares |
| Trading Value | $248M |
| Per Share | |
| EPS | $7.31 |
| BPS | $24.11 |